Abstract:Objective: To determine how dysfunctional astrocyte glutamate transporters contribute to microglial pruning of glutamatergic synapses and memory deficiency in Alzheimer’s disease (AD). Background: Astrocytes are the most abundant and heterogeneous type of glial cells in the brain, we tested the hypothesis that amyloid fibrils impair astrocyte glutamate transporters, thus leading to an abnormal accumulation of extrasynaptic glutamate, which in turn contributes to microglial pruning of glutamatergic synapses and memory deficiency in the rodent models of AD. Design/Methods: Aβ1–40 fibrils were microinjected bilaterally into hippocampal CA1 areas in rats. In another cohorts, DL-threo-beta-benzyloxyaspartate (DL-TBOA), a specific inhibitor of glutamate transporter 1 (GLT1), or ceftriaxone (used to enhance GLT1 function) were also microinjected into hippocampal CA1 areas. Immunostaining and immunoblotting were performed to detect the expression of GLT1 in astrocytes. Complement C1q production and microglial pruning of glutamatergic synapses were assessed by 3D immunofluorescence imaging. Morris water maze test was performed to evaluate the cognitive function. Results: A significant GLT1 reduction in the hippocampal astrocytes in rats injected with amyloid fibrils, indicating dysfunctional glutamate uptake. Microinjection of ceftriaxone significantly attenuated C1q expression and endocytosis of vGluT1 within microglia, and improved behavioral performance in the modeled rats. These results suggested that upregulation of GluT1 expression restored the synaptic microglial pruning and cognition impaired by amyloid fibrils. Meanwhile, in naive rats, microinjection of DL-TBOA substantially increased C1q expression, increased localization of vGluT1 within microglia, and impaired performance in the Morris water maze. This suggests that dysfunctional GluT1, which likely leads to extracellular accumulation of glutamate, contributes to C1q-mediated microglial pruning of synapses and cognitive deficits induced by amyloid fibrils. Conclusions: Reduction of astrocytic GLT1 contributes to C1q production and microglial pruning of glutamatergic synapses, hippocampal synaptic dysfunction and memory deficit in the AD model. Disclosure: Dr. Wu has nothing to disclose. Dr. Bie has nothing to disclose. Dr. Naguib has nothing to disclose.

Interaction of DCF1 with ATP1B1 Induces Impairment in Astrocyte Structural Plasticity Via the P38 Signaling Pathway.

Astrocytes Gate Long-Term Potentiation in Hippocampal Interneurons

Energy Failure in Astrocytes Increases the Vulnerability of Neurons to Spreading Depression.

Excessive astrocyte-derived neurotrophin-3 contributes to the abnormal neuronal dendritic development in a mouse model of fragile X syndrome.

Group I Mglur Antagonist Rescues the Deficit of D1-induced LTP in a Mouse Model of Fragile X Syndrome

Improvement of Learning and Memory by Elevating Brain D-Aspartate in a Mouse Model of Fragile X Syndrome.

Tet1 Regulates Astrocyte Development and Cognition of Mice Through Modulating GluA1

Astrocytic AT1R deficiency ameliorates Aβ-induced cognitive deficits and synaptotoxicity through β-arrestin2 signaling

ATP11B Deficiency Leads to Impairment of Hippocampal Synaptic Plasticity.

Astrocytes Contribute to Synapse Elimination Via Type 2 Inositol 1,4,5-Trisphosphate Receptor-Dependent Release of ATP

Dcf1 Deficiency Attenuates the Role of Activated Microglia During Neuroinflammation.

Dcf1 Triggers Dendritic Spine Formation and Facilitates Memory Acquisition

Alzheimer’s Disease Enhanced Tonic Inhibition is Correlated With Upregulated Astrocyte GABA Transporter-3/4 in a Knock-In APP Mouse Model

Regulation of blood-brain barrier integrity by Dmp1 -expressing astrocytes through mitochondrial transfer

Reduction of Astrocytic Glutamate Transporter Contributes to Amyloid-induced phagocytosis

Astrocytes Render Memory Flexible by Releasing D-Serine and Regulating NMDA Receptor Tone in the Hippocampus.

Impairments in Endogenous AMPA Receptor Dynamics Correlates with Learning Deficits in Alzheimer's Disease Model Mice.

Fluorocitrate Induced the Alterations of Memory-Related Proteins and Tau Hyperphosphorylation in SD Rats.

Impaired calcium signaling in astrocytes modulates autism spectrum disorder-like behaviors in mice

Purinergic Signalling Mediates Aberrant Excitability of Developing Neuronal Circuits in the Fmr1 Knockout Mouse Model